Atovaquone and proguanil for the treatment of malaria in Brazil

Journal of Infectious Diseases

Volumn 175, Issue 6, 1997, Pages 1544-1547

  De Alencar, Filomena E C ^b   Cerutti Jr , Crispim ^b   Durlacher, Rui Rafael ^b   Boulos, Marcos ^b   Alves, Fabiana Piovesan ^b   Milhous, Wilbur ^b   Pang, Lorrin W ^a  

^a AM CONGEN RIO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CHLOROQUINE; MEFLOQUINE; PRIMAQUINE; PROGUANIL; QUININE; TETRACYCLINE;

ABDOMINAL PAIN; ADULT; AGED; ANTIMALARIAL ACTIVITY; ARTICLE; BRAZIL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MULTIDRUG RESISTANCE; NAUSEA; PARASITEMIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TINNITUS; TREATMENT OUTCOME; VERTIGO;

EID: 0030922611     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516497     Document Type: Article

References (15)

1. Fundação Nacional de Sau̇de. Lâminas positivas para malȧria. Brasil e Estado de São Paulo, 1965 a 1993 (table). In: Outra AP, Alves MCGP, Pereira M. Relatório de Avaliação do Programa de Controle de Malȧria. Estado de São Paulo. Periodo de 1992 a 1994. Sāo Paulo: Superintendência de Controle de Endemias - SUCEN. Divisão de Orientaçāo Técnica, 1995:2.
2. Neifer S, Kremnes PG. Drug susceptibility of Plasmodium falcipamm in the western Amazon region, state of Acre, Brazil. Rev Inst Med Trop Sao Paulo 1991;33:205-11.
3. Fundação Nacional de Sau̇de/Gerência Tėcnica de Malária. Manual de terapêutica de malária. Brasilia, Brazil: Ministério da Sau̇de, 1990: 49-50.
4. Duy SY, Boi N, Hoan D, et al. Treatment of malaria in Vietnam with oral artemisinin. Am J Trop Med Hyg 1993;48:398-402.
5. Wellcome Research Laboratories. Atovaquone tablet, intravenous and oral suspension formulations. Atovaquone (trans-2-[4-(4-chlorophenyl)ciclohexyl]-3-hydroxy-l,4 naphtoquinone. Information for investigators. Beckenham, UK: Wellcome Research Laboratories, 11 October 1991, revised 31 August 1992 (final):31; publication no. THIB/92/0004.115/ W4(5).
6. Gutteridge WE. 566C80, an antimalarial hydroxynaphthoquinone with broad spectrum: experimental activity against opportunistic parasitic infections of AIDS patients. J Protozool 1991;38:141S-3S.
7. Romand S, Pudney M, Derouin F. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrob Agents Chemother 1993;37:2371-8.
8. Dohn MN, Weinberg WG, Torres RA, et al. Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med 1994;121:174-80.
9. Fowler RE, Sinden RE, Pudney M. Inhibitory activity of the anti-malarial atovaquone (566C80) against ookinetes, oocysts and sporozoites of Plasmodium berghei. J Parasitol 1995;81:452-8.
10. Hughes W, Leoung G, Kramer F, et al. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat P. carinii in patients with AIDS. N Engl J Med 1993;328:1521-7.
11. Hutchinson DBA. Clinical evaluation of atovaquone in the treatment of malaria (abstract). In: XIIIth International Congress for Tropical Medicine and Malaria (Jomtien, Pattaya, Thailand). Vol 1. 1992:201.
12. Canfield CJ, Pudney M, Gutteridge WE. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol 1995;80:373-81.
13. Fontanet AL, Johnston BD, Walker AM, Bergqvist Y, Hellgreen U, Rooney W. Falciparum malaria in eastern Thailand: a randomized trial of the efficacy of a single dose of mefloquine. Bull World Health Organ 1994;72:73-8.
14. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am J Trop Med Hyg 1994; 50:784-9.
15. Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG. Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 1996; 347:1511-4.